Table 1.
Author, year | Study type | N* (I;C) | Date of intervention | Participants (setting) | Duration | Study design and comparison | Retention rates† (%) total (I:C) | Intervention | |
EHR-sharing component | Other components of the intervention | ||||||||
Chrischilles, 2013 29 | RCT | 1075 (I:802; C:273) |
2010–2011 | General population (>65 years old) (general public—survey to voters) |
6 M | 2-arm study Standard care control group |
100.0 (I:100.0; C:100.0) |
|
|
Earnest, 2004 21 | RCT | 107 (I:54; C:53) |
2002 | Patients with chronic heart failure (secondary care) |
12 M | 2-arm study Standard care control group |
75.7 (I:70.4; C:81.1) |
|
|
Fonda, 2009 14 | RCT | 104 (I:52; C:52) |
NA | Patients with poorly controlled T2DM (primary and secondary care) |
12 M | 2-arm study Standard care control group |
NA |
|
|
Grant, 2008 33 | RCT | 244 (I:126; C:118) |
2005– 2007 |
General population (primary care) |
12 M | 2-arm study Active care control group (ie, access to a PHR to update and submit family history and health maintenance information) |
64.0 (I:65.0; C:34.7) |
|
|
Green,
2008 23 |
RCT | 778 (I1:259; I2:261; C:258) |
NA | Hypertensive patients (primary and secondary care) |
12 M | 3-arm study Standard care control group Intervention 1(I1): home BP monitoring and secure patient Web services training only Intervention 2(I2): home BP monitoring and Web training plus pharmacist care management delivered through web communications In this work, only control and intervention one were considered |
93.8 (I1:94.9; I2:90.8; C:95.7) |
|
|
Holbrook, 2009 15 | RCT | 511 (I:253; C:258) |
2002– 2003 |
Patients with type 2 diabetes (primary care) |
6 M | 2-arm study Standard care control group |
68.7 (I:68.4; C:69.0) |
|
|
Jones,
1999 25 |
RCT | 525 (I1:167; I2:178; C:180) |
1997 | Radiotherapy patients (secondary care) | 3 M | 3-arm study Standard care control group Intervention 1(I1): Access to general information on a computer) Intervention 2(I2): Access to personal and general information in varying order via a computer In this work only comparisons between control and I2 will be considered |
83.4 (I1:76.6; I2:87.6; C:85.6) |
|
|
Khan,
2010 16 |
RCT | 7368 (I:3856; C:3512) |
NA | Patients with type 2 diabetes (primary and secondary care) | 32 M | 2-arm study Standard care control group |
100.0 (I:100.0; C:100.0) |
|
|
Krist,
2012 32 |
RCT | 4500 (I:2250: C:2250) | 2008– 2009 |
General population (primary care) |
16 M | 2-arm study Standard care control group |
NA |
|
|
McCarrier, 2009 26 | RCT | 78 (I:42; C:36) |
2005– 2006 |
Patients with type 1 diabetes (primary care) | 12 M | 2-arm study Standard care control group |
83.3 (I:85.7; C:80.6) |
|
|
McMahon, 2005 17 | RCT | 104 (I:52; C:52) |
2004 | Patients with type 2 diabetes patients (both primary and secondary care) | 12 M | 2-arm study Standard care control group |
75.9 (I:75.0; C:76.9) |
|
|
Nagykaldi, 2012 31 | CRT | 384 (I:NA; C:NA) |
NA | General population (primary care) | 12 M | 2-arm study Standard care control group |
68.5 (I:NA; C:NA) |
|
|
Quinn, 2008 19 | RCT | 26 (I:13; C:13) |
2006 | Patients with type 2 diabetes patients (primary care) | 3 M | 2-arm study Standard care control group |
NA |
|
|
Ralston, 2009 18 | RCT | 83 (I:42; C:41) |
2002– 2004 |
Patients with type 2 diabetes (secondary care) |
12 M | 2-arm study Standard care control group |
90.3 (I:92.95; C:87.8) |
|
|
Ross,
2004 22 |
RCT | 107 (I:54; C:53) |
2001 | Patients with heart failure (secondary care) | 12 M | 2-arm study Standard care control group |
75.7 (I:81.1; C:70.3) |
|
|
Schnipper, 2012 30 | CRT | 541 (I:267; C:274) |
2005– 2007 |
General population (primary care) |
NA | 2-arm study Active care control group (ie, patients received a different EHR-linked intervention) |
74.3% (I:100.0% C:49.3%) |
|
|
Shaw,
2008 28 |
RCT | 193 (I:97; C:96) |
2004– 2006 |
Maternity centre (primary care) |
NA | 2-arm study Active care control group (ie, patients received access to the same website but with links to general pregnancy health information alone) |
54.9 (I:64.9; C:44.8) |
|
|
Tang,
2013 20 |
RCT | 415 (I:202; C:213) |
2008– 2009 |
Patients with type 2 diabetes patients (both primary and secondary care) | 12 M | 2-arm study Standard care control group |
91.3 I:92.0; C:90.6 |
|
|
Tuil,
2007 27 |
RCT | 244 (I:122; C:122) |
2004 | Patients undergoing IVF or ICSI (secondary care) | NA | 2-arm study Standard care control group |
73.7 (I:83.6; C:63.9) |
|
|
Wagner, 2012 24 | CRT | 443 (I:194; C:252) |
NA | Patients with hypertension (both primary and secondary care) |
12 M | 2-arm study Standard care control group |
71.9 (I:61.8; C:75.8) |
|
|
*Total number of participants randomised for each study.
†Retention rates were calculated as the proportion of patients randomised in each study that completed follow-up.
BP, blood pressure; C, Control group; CRT, cluster randomised trial; EHR, electronic health records; HCP, healthcare professionals; I, Intervention group; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilisation; LDL, low-density lipoprotein; M, months; NA, information not available; PHR, personal health record; RCT, randomised controlled trial; T2DM, type 2 diabetes mellitus.